Home/Filings/4/0001415889-25-008714
4//SEC Filing

TZIANABOS ARTHUR 4

Accession 0001415889-25-008714

CIK 0001623526other

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 6:18 PM ET

Size

5.5 KB

Accession

0001415889-25-008714

Insider Transaction Report

Form 4
Period: 2025-03-20
TZIANABOS ARTHUR
DirectorInterim Executive Chair
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-03-20+122,651122,651 total
    Exercise: $8.33Exp: 2035-03-19Common Stock (122,651 underlying)
Footnotes (1)
  • [F1]The option vests ratably as to 1/12 of the total award on the monthly anniversary of the grant date, subject to the reporting person's continued service to the Issuer on each vesting date.

Issuer

Stoke Therapeutics, Inc.

CIK 0001623526

Entity typeother

Related Parties

1
  • filerCIK 0001586226

Filing Metadata

Form type
4
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 6:18 PM ET
Size
5.5 KB